Identification of CFTR activators and inhibitors: Chance or design?

Current Opinion in Pharmacology

Volumn 4, Issue 5, 2004, Pages 497-503

  Galietta, Luis J V ^a   Moran, Oscar ^b  

^a G GASLINI INSTITUTE   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID DERIVATIVE; ALPHA NAPHTHOFLAVONE; BENZOTHIOPHENE DERIVATIVE; CHLORIDE CHANNEL; EFENAMIC ACID; ENTEROTOXIN; GLIBENCLAMIDE; ION TRANSPORT AFFECTING AGENT; PROTEIN INHIBITOR; SULFONYLUREA; THIAZOLE DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRANSMEMBRANE CONDUCTANCE REGULATOR ACTIVATOR; TRANSMEMBRANE CONDUCTANCE REGULATOR ACTIVATOR 172; TRANSMEMBRANE CONDUCTANCE REGULATOR INHIBITOR; UNCLASSIFIED DRUG; XANTHINE; CFTR PROTEIN, HUMAN;

ARTICLE; CHLORIDE TRANSPORT; CYSTIC FIBROSIS; DIARRHEA; DRUG DESIGN; DRUG STRUCTURE; DRUG TARGETING; EPITHELIUM CELL; GENE MUTATION; HIGH THROUGHPUT SCREENING; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; PHYSIOLOGY; REVIEW;

ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DRUG DESIGN; HUMANS;

EID: 15944377776     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.04.008     Document Type: Review

References (55)

1. J.M. Pilewski R.A. Frizzell Role of CFTR in airway disease Physiol Rev 79 1999 S215-S255
2. D.N. Sheppard M.J. Welsh Structure and function of the CFTR chloride channel Physiol Rev 79 1999 S23-S45
3. L. Schmitt R. Tampe Structure and mechanism of ABC transporters Curr Opin Struct Biol 12 2002 754-760
4. G. Verdon S.V. Albers B.W. Dijkstra A.J. Driessen A.M. Thunnissen Crystal structures of the ATPase subunit of the glucose ABC transporter from Sulfolobus solfataricus: Nucleotide-free and nucleotide-bound conformations J Mol Biol 330 2003 343-358
5. G. Chang Multidrug resistance ABC transporters FEBS Lett 555 2003 102-105
6. G. Chang C.B. Roth Structure of MsbA from E. coli: A homolog of the multidrug resistance ATP binding cassette (ABC) transporters Science 293 2001 1793-1800
7. K.P. Locher A.T. Lee D.C. Rees The E. coli BtuCD structure: A framework for ABC transporter architecture and mechanism Science 296 2002 1091-1098
8. H.A. Lewis S.G. Buchanan S.K. Burley K. Conners M. Dickey M. Dorwart R. Fowler X. Gao W.B. Guggino W.A. Hendrickson et al. Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator EMBO J 23 2004 282-293
9. D.C. Gadsby A.C. Nairn Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis Physiol Rev 79 1999 S77-S107
10. - channels J Gen Physiol 121 2003 17-36
11. Q. Al-Awqati Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors J Clin Invest 110 2002 1599-1601
12. J.L. Bobadilla M. Macek Jr. J.P. Fine P.M. Farrell Cystic fibrosis: A worldwide analysis of CFTR mutations-correlation with incidence data and application to screening Hum Mutat 19 2002 575-606
13. W. Dalemans P. Barbry G. Champigny S. Jallat K. Dott D. Dreyer R.G. Crystal A. Pavirani J.P. Lecocq M. Lazdunski Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation Nature 354 1991 526-528
14. G.M. Denning M.P. Anderson J.F. Amara J. Marshall A.E. Smith M.J. Welsh Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive Nature 358 1992 761-764
15. R.R. Kopito Biosynthesis and degradation of CFTR Physiol Rev 79 1999 S167-S173
16. B. Illek L. Zhang N.C. Lewis R.B. Moss J.Y. Dong H. Fischer Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein Am J Physiol 277 1999 C833-C839
17. D.C. Devor R.J. Bridges J.M. Pilewski Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia Am J Physiol Cell Physiol 279 2000 C461-C479
18. O. Zegarra-Moran L. Romio C. Folli E. Caci F. Becq J.M. Vierfond Y. Mettey G. Cabrini P. Fanen L.J.V. Galietta Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07 Br J Pharmacol 137 2002 504-512
19. A. Taddei C. Folli O. Zegarra-Moran P. Fanen A.S. Verkman L.J.V. Galietta Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker FEBS Lett 558 2004 52-56
20. A.A. Kochegarov Pharmacological modulators of voltage-gated calcium channels and their therapeutical application Cell Calcium 33 2003 145-162
21. P.J. Whiting GABA-A receptor subtypes in the brain: A paradigm for CNS drug discovery? Drug Discov Today 8 2003 445-450
22. C.M. Haws I.B. Nepomuceno M.E. Krouse H. Wakelee T. Law Y. Xia H. Nguyen J.J. Wine Delta F508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines Am J Physiol 270 1996 C1544-C1555
23. L. Bulteau R. Derand Y. Mettey T. Metaye M.R. Morris C.M. McNeilly C. Folli L.J. Galietta O. Zegarra-Moran M.M. Pereira et al. Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells Am J Physiol Cell Physiol 279 2000 C1925-C1937
24. R. Derand L. Bulteau-Pignoux Y. Mettey O. Zegarra-Moran L.D. Howell C. Randak L.J. Galietta J.A. Cohn C. Norez L. Romio et al. Activation of G551D CFTR channel with MPB-91: Regulation by ATPase activity and phosphorylation Am J Physiol Cell Physiol 281 2001 C1657-C1666
25. C. Marivingt-Mounir C. Norez R. Derand L. Bulteau-Pignoux D. Nguyen-Huy B. Viossat G. Morgant F. Becq J.M. Vierfond Y. Mettey Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels J Med Chem 47 2004 962-972
26. - current by phloxine B Br J Pharmacol 131 2000 433-440
27. Z. Cai D.N. Sheppard Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity J Biol Chem 277 2002 19546-19553
28. M. Duszyk L. MacVinish A.W. Cuthbert Phenanthrolines - a new class of CFTR chloride channel openers Br J Pharmacol 134 2001 853-864
29. E. Caci C. Folli O. Zegarra-Moran T. Ma M.F. Springsteel R.E. Sammelson M.H. Nantz M.J. Kurth A.S. Verkman L.J.V. Galietta CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds Am J Physiol Lung Cell Mol Physiol 285 2003 L180-L188
30. D.C. Dawson S.S. Smith M.K. Mansoura CFTR: Mechanism of anion conduction Physiol Rev 79 1999 S47-S75
31. B.D. Schultz A.K. Singh D.C. Devor R.J. Bridges Pharmacology of CFTR chloride channel activity Physiol Rev 79 1999 S109-S144
32. N.A. McCarty Permeation through the CFTR chloride channel J Exp Biol 203 2000 1947-1962
33. - channels expressed in a murine cell line J Physiol 503 1997 333-346
34. Z. Zhou S. Hu T.C. Hwang Probing an open CFTR pore with organic anion blockers J Gen Physiol 120 2002 647-662
35. - channel Pflugers Arch 429 1995 659-662
36. S. McDonough N. Davidson H.A. Lester N.A. McCarty Novel pore-lining residues in CFTR that govern permeation and open-channel block Neuron 13 1994 623-634
37. S. Jayaraman P. Haggie R.M. Wachter S.J. Remington A.S. Verkman Mechanism and cellular applications of a green fluorescent protein-based halide sensor J Biol Chem 275 2000 6047-6050
38. L.J.V. Galietta P.M. Haggie A.S. Verkman Green fluorescent protein-based halide indicators with improved chloride and iodide affinities FEBS Lett 499 2001 220-224
39. A.S. Verkman Drug discovery in academia Am J Physiol 286 2004 C465-C474
40. L.J. Galietta M.F. Springsteel M. Eda E.J. Niedzinski K. By M.J. Haddadin M.J. Kurth M.H. Nantz A.S. Verkman Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds J Biol Chem 276 2001 19723-19728
41. T. Ma L. Vetrivel H. Yang N. Pedemonte O. Zegarra-Moran L.J. Galietta A.S. Verkman High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening J Biol Chem 277 2002 37235-37241
42. H. Yang A.A. Shelat R.K. Guy V.S. Gopinath T. Ma K. Du G.L. Lukacs A. Taddei C. Folli N. Pedemonte et al. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating J Biol Chem 278 2003 35079-35085
43. T. Ma J.R. Thiagarajah H. Yang N.D. Sonawane C. Folli L.J. Galietta A.S. Verkman Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion J Clin Invest 110 2002 1651-1658
44. J.R. Thiagarajah Y. Song P.M. Haggie A.S. Verkman A small molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland fluid secretions in normal airways FASEB J 18 2004 875-877
45. Gray MA Designer pharmacotherapy for the treatment of cystic fibrosis: commentary on Zegarra-Moran et al Br J Pharmacol 137 2002 411-412
46. T. Lengauer C. Lemmen M. Rarey M. Zimmermann Novel technologies for virtual screening Drug Discov Today 9 2004 27-34
47. M.F. Springsteel L.J.V. Galietta T. Ma K. By G.O. Berger H. Yang C.W. Dicus W. Choung C. Quan A.A. Shelat et al. Benzoflavone activators of the cystic fibrosis transmembrane conductance regulator: Towards a pharmacophore model for the nucleotide-binding domain Bioorg Med Chem 11 2003 4113-4120
48. H.-J. Bohm M. Boehringer D. Bur H. Gmuender W. Huber W. Klaus D. Kostrewa H. Kuehne T. Luebbers N. Meunier-Keller F. Mueller Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening J Med Chem 43 2000 2664-2674
49. P.D. Lyne Structure-based virtual screening: An overview Drug Discov Today 7 2002 1047-1055
50. G. Schneider H.J. Bohm Virtual screening and fast automated docking methods Drug Discov Today 7 2002 64-70
51. P.D. Lyne P.W. Kenny D.A. Cosgrove C. Deng S. Zabludoff J.J. Wendoloski S. Ashwell Identification of compounds with nanomolar affinity for checkpoint kinase-1 using knowledge-based virtual screening J Med Chem 47 2004 1962-1968
52. R. Derand L. Bulteau-Pignoux F. Becq The cystic fibrosis mutation G551D alters the non-Michaelis-Menten behavior of the cystic fibrosis transmembrane conductance regulator (CFTR) channel and abolishes the inhibitory Genistein binding site J Biol Chem 277 2002 35999-36004
53. S.J. Campbell N.D. Gold R.M. Jackson D.R. Westhead Ligand binding: functional site location, similarity and docking Curr Opin Struct Biol 13 2003 389-395
54. O. Dror A. Shulman-Peleg R. Nussinov H.J. Wolfson Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design Curr Med Chem 11 2004 71-90
55. N. Brooijmans I.D. Kuntz Molecular recognition and docking algorithms Annu Rev Biophys Biomol Struct 32 2003 335-373